Bromoacetylalprenololmenthane
![]()  | |
| Names | |
|---|---|
| IUPAC name  2-bromo-N-[2-[4-[[2-hydroxy-3-(2-prop-2-enylphenoxy)propyl]amino]-4-methylcyclohexyl]propan-2-yl]acetamide   | |
| Identifiers | |
3D model (JSmol)   |  |
| Abbreviations | BAAM, BrAAM | 
| ChEMBL | |
| ChemSpider | |
| MeSH | Bromoacetylalprenololmenthane | 
PubChem CID   |  |
CompTox Dashboard (EPA)   |  |
  | |
  | |
| Properties | |
| C24H37BrN2O3 | |
| Molar mass | 481.475 g·mol−1 | 
| log P | 4.14 | 
| Acidity (pKa) | 13.844 | 
| Basicity (pKb) | 0.153 | 
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).  Infobox references   | |
Bromoacetylalprenololmenthane (BAAM or BrAAM) is a β adrenergic receptor agonist.[1]
References
- ^ Rainer-Joachim; Matthys Staehelin (20 April 1987). "Bromoacetylalprenololmenthane binding to β-receptors modulates the rate of hormone-induced internalization but not desensitization in S49 cells". FEBS Letters. 214 (2): 323–326. doi:10.1016/0014-5793(87)80079-0. PMID 3032686.
 
